Boric Acid

Boric Acid

SCHEMBL6312485

CS(=O)(=O)Nc1ccccc1.OB(O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 1/20 0.83
PGR P06401 1/20 0.58
NR3C2 P08235 5/20 0.56
PTGS2 P35354 2/20 0.56
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50
HTT P42858 1/20 0.50
NPC1 O15118 1/20 0.50
AR P10275 1/20 0.50
RAB9A P51151 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CASP1 P29466 1/20 0.50
CASP7 P55210 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL56693 0.91 KEAP1 (1.00) KEAP1PGRNR3C2PTGS2SMN1; SMN2
Hydrochloric Acid SCHEMBL27365433 0.89 KEAP1 (0.95) KEAP1PGRNR3C2PTGS2SMN1; SMN2
SCHEMBL11512295 0.89 KEAP1 (0.95) KEAP1PGRNR3C2PTGS2SMN1; SMN2
Hydrogen Sulfide SCHEMBL27698561 0.89 KEAP1 (0.95) KEAP1PGRNR3C2PTGS2SMN1; SMN2
Fluoride SCHEMBL28258745 0.89 KEAP1 (0.95) KEAP1PGRNR3C2PTGS2SMN1; SMN2
SCHEMBL1358244 0.87 KEAP1 (0.83) KEAP1PGRNR3C2PTGS2SMN1; SMN2
SCHEMBL9479898 0.83 KEAP1 (0.83) KEAP1PGRNR3C2PTGS2SMN1; SMN2
SCHEMBL28319287 0.80 KEAP1 (0.70) KEAP1PGRNR3C2PTGS2SMN1; SMN2
SCHEMBL9387480 0.79 KEAP1 (0.76) KEAP1PGRNR3C2PTGS2SMN1; SMN2
Ethyl Chloride SCHEMBL27421992 0.79 KEAP1 (0.76) KEAP1PGRNR3C2PTGS2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014810-A1 Use of substituted 2 phenylbenzimidazoles as medicaments BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014810-A1 Use of substituted 2 phenylbenzimidazoles as medicaments GLP1R, GIPR, GCGR KEAP1 3907/4885PGR 84/4885NR3C2 340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.